PharmacoEconomics & Outcomes News Weekly


ISSN: 1173-5503        年代:2003
当前卷期:Volume &NA;  issue 433     [ 查看所有卷期 ]

年代:2003
 
     Volume 421  issue &NA;   
     Volume &NA;  issue 394   
     Volume &NA;  issue 395   
     Volume &NA;  issue 396/397   
     Volume &NA;  issue 398   
     Volume &NA;  issue 399   
     Volume &NA;  issue 400   
     Volume &NA;  issue 401   
     Volume &NA;  issue 402   
     Volume &NA;  issue 403   
     Volume &NA;  issue 404   
     Volume &NA;  issue 405   
     Volume &NA;  issue 406   
     Volume &NA;  issue 407   
     Volume &NA;  issue 408/09   
     Volume &NA;  issue 410   
     Volume &NA;  issue 411   
     Volume &NA;  issue 412   
     Volume &NA;  issue 413   
     Volume &NA;  issue 414   
     Volume &NA;  issue 415   
     Volume &NA;  issue 416   
     Volume &NA;  issue 417   
     Volume &NA;  issue 418   
     Volume &NA;  issue 419   
     Volume &NA;  issue 420   
     Volume &NA;  issue 422   
     Volume &NA;  issue 423   
     Volume &NA;  issue 424   
     Volume &NA;  issue 425   
     Volume &NA;  issue 426   
     Volume &NA;  issue 427   
     Volume &NA;  issue 428   
     Volume &NA;  issue 429   
     Volume &NA;  issue 430   
     Volume &NA;  issue 431   
     Volume &NA;  issue 432   
     Volume &NA;  issue 433
     Volume &NA;  issue 434   
     Volume &NA;  issue 435   
     Volume &NA;  issue 436   
     Volume &NA;  issue 437   
     Volume &NA;  issue 438   
     Volume &NA;  issue 439   
     Volume &NA;  issue 440   
     Volume &NA;  issue 441   
     Volume &NA;  issue 442   
     Volume &NA;  issue 443   
1. Health-related philanthropy"alive and well"
  PharmacoEconomics & Outcomes News Weekly,   Volume  &NA;,   Issue  433,   2003,   Page  2-2

&NA;,  

Preview

2. Which antifungal agents best value for money in the US?
  PharmacoEconomics & Outcomes News Weekly,   Volume  &NA;,   Issue  433,   2003,   Page  3-4

&NA;,  

Preview

3. The US National Comprehensive Cancer Network (NCCN) and the American Cancer Society have produced the NCCN Breast Cancer Treatment Guidelines for Patients
  PharmacoEconomics & Outcomes News Weekly,   Volume  &NA;,   Issue  433,   2003,   Page  5-5

&NA;,  

Preview

4. One in four parents or guardians report delaying the treatment of their child's allergies,
  PharmacoEconomics & Outcomes News Weekly,   Volume  &NA;,   Issue  433,   2003,   Page  6-6

&NA;,  

Preview

5. Irbesartan cost effective in French, Belgian settings
  PharmacoEconomics & Outcomes News Weekly,   Volume  &NA;,   Issue  433,   2003,   Page  7-7

&NA;,  

Preview

6. Antihypertensive prescriptions increase in Canada
  PharmacoEconomics & Outcomes News Weekly,   Volume  &NA;,   Issue  433,   2003,   Page  8-8

&NA;,  

Preview

7. Costs of rare haemophilia complication substantial in Italy
  PharmacoEconomics & Outcomes News Weekly,   Volume  &NA;,   Issue  433,   2003,   Page  9-9

&NA;,  

Preview

8. Epoetin alfa improves QOL in anaemic patients with cancer
  PharmacoEconomics & Outcomes News Weekly,   Volume  &NA;,   Issue  433,   2003,   Page  10-10

&NA;,  

Preview

9. UK nurses, others to prescribe controlled drugs
  PharmacoEconomics & Outcomes News Weekly,   Volume  &NA;,   Issue  433,   2003,   Page  11-11

&NA;,  

Preview

10. The US CMS*has been commended by pharmaceutical company Chiron Corporation for implementing a reimbursement change on 1 October that will increase access to high-dose interleukin-2 (IL-2)
  PharmacoEconomics & Outcomes News Weekly,   Volume  &NA;,   Issue  433,   2003,   Page  12-12

&NA;,  

Preview

首页 上一页 下一页 尾页 第1页 共10条